Evolus Ownership

Who are the major shareholders and have insiders been buying or selling?


Recent Insider Transactions

LSE:0K16 Recent Insider Transactions by Companies or Individuals
DateValueNameEntityRoleSharesMax Price
06 Sep 24SellUS$49,074Sandra BeaverIndividual3,276US$14.98
30 Aug 24SellUS$89,251Tomoko Yamagishi-DresslerIndividual5,631US$15.85
04 Jun 24SellUS$1,784,686David MoatazediIndividual140,214US$12.73
03 Jun 24SellUS$97,203Vikram MalikIndividual7,500US$12.96
14 May 24SellUS$131,010David GillIndividual10,361US$12.72
13 May 24SellUS$362,012Vikram MalikIndividual28,000US$12.93
10 May 24SellUS$30,814Sandra BeaverIndividual2,423US$12.72
10 May 24SellUS$43,761Rui AvelarIndividual3,441US$12.72
10 May 24SellUS$204,127David MoatazediIndividual16,051US$12.72
27 Mar 24SellUS$86,431David MoatazediIndividual6,236US$13.86
19 Mar 24SellUS$1,344,604David MoatazediIndividual96,566US$13.92
19 Mar 24SellUS$78,978Sandra BeaverIndividual5,672US$13.92
19 Mar 24SellUS$384,350Rui AvelarIndividual27,603US$13.92
22 Feb 24SellUS$100,804David MoatazediIndividual7,706US$13.08
08 Dec 23SellUS$822,396David MoatazediIndividual82,648US$10.09

Insider Trading Volume

Insider Buying: 0K16 insiders have only sold shares in the past 3 months.


Ownership Breakdown

What is the ownership structure of 0K16?
Owner TypeNumber of SharesOwnership Percentage
Individual Insiders1,248,0321.97%
Public Companies3,136,8694.95%
Private Companies3,381,3265.34%
General Public4,789,3227.56%
VC/PE Firms5,356,6228.46%
Institutions45,409,32271.7%

Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 10.8%.


Top Shareholders

Top 25 shareholders own 73% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
8.46%
Perceptive Advisors LLC
5,356,622US$73.3m-6.9%1.55%
7.66%
Tang Capital Management, LLC
4,847,399US$66.4m0%4.7%
6.68%
BlackRock, Inc.
4,230,149US$57.9m5.54%no data
5.34%
Medytox Korea Co. Ltd
3,381,326US$46.3m0%no data
5.05%
The Vanguard Group, Inc.
3,195,331US$43.7m7.04%no data
4.95%
Daewoong Pharmaceutical Co., Ltd
3,136,869US$42.9m0%no data
4.46%
Nantahala Capital Management, LLC
2,824,849US$38.7m-2.95%2.72%
3.46%
Caligan Partners, LP
2,193,488US$30.0m1.19%8.67%
2.16%
Stonepine Capital Management LLC
1,369,821US$18.8m-17.4%6.13%
2.02%
State Street Global Advisors, Inc.
1,277,841US$17.5m-4.57%no data
1.91%
Geode Capital Management, LLC
1,210,621US$16.6m0.92%no data
1.85%
Great Point Partners, LLC
1,170,000US$16.0m-52.3%5.5%
1.64%
Soleus Capital Management, L.P.
1,037,680US$14.2m-9.92%1.0%
1.63%
Millennium Management LLC
1,029,670US$14.1m14.5%0.01%
1.6%
Schroder Investment Management North America Inc.
1,014,960US$13.9m3.82%0.04%
1.57%
Lord, Abbett & Co. LLC
995,449US$13.6m23.4%0.04%
1.55%
Boothbay Fund Management, LLC
983,702US$13.5m-1.29%0.43%
1.55%
Morgan Stanley, Investment Banking and Brokerage Investments
979,326US$13.4m-31.7%no data
1.53%
D. E. Shaw & Co., L.P.
970,270US$13.3m11.4%0.02%
1.51%
Assenagon Asset Management S.A.
955,555US$13.1m0.89%0.02%
1.43%
Rice Hall James & Associates, LLC
904,900US$12.4m6.3%0.64%
1.41%
Teachers Insurance and Annuity Association-College Retirement Equities Fund
894,742US$12.2m50.6%no data
1.34%
Soros Fund Management LLC
850,000US$11.6m0%0.3%
1.19%
UBS Asset Management AG
753,532US$10.3m-2.06%no data
1.04%
AWH Capital, L.P.
657,500US$9.0m-2.59%7.65%